Search for Clinical Trial Results

Sponsored By

Ovarian Epithelial Cancer - 24 Studies Found

Status Study
Not yet recruiting Study Name: Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France
Condition: Ovarian Epithelial Cancer
Date: 2016-11-28
Interventions: Other: Patient with ovarian epithelial cancer
Completed Study Name: Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Condition:
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer Date: 2001-05-06
    Interventions: Biological: recombinant interleukin-12 Given intraperitoneally
Withdrawn Study Name: Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
Condition: Ovarian Carcinoma
Date: 2008-04-10
Interventions: Drug: Fondaparinux Arixtra 2.5 mg by subcutaneous injection once daily for 8 weeks or until disease recu
Completed Study Name: Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Condition: Ovarian Epithelial Cancer
Date: 2017-03-04
Interventions: Drug: SPL-108 Subcutaneous injection of 150 mg administered either one time or two times per day.
Active, not recruiting Study Name: Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma
Condition:
  • Ovarian Neoplasms
  • Ovarian Epithelial Cancer

Date: 2014-04-04
Interventions:
  • Biological: DCVAC/OvCa with Standard of Care

Active, not recruiting Study Name: Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
Condition: Ovarian Carcinoma
Date: 2008-07-14
Interventions:
  • Other: timing of surgery Surge
Withdrawn Study Name: Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity
Condition: Recurrent Ovarian Carcinoma
Date: 2009-07-17
Interventions:
  • Drug: Cisplatin PLATINOL®
Not yet recruiting Study Name: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Date: 2012-09-04
Active, not recruiting Study Name: Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)
Condition: Ovarian Carcinoma
Date: 2014-09-15
Interventions:
  • Device: NovoTTF-100L(O) Patien
Terminated Study Name: A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Epithelial Ovarian Cancer
Date: 2013-03-18
Interventions:
  • Drug: CAELYX CAELYX 50 mg per

Next >>>